Pharmaceutical Companies Rush To Patent Medical Marijuana

It seems like one of the greatest fears of the medical marijuana community is slowly being realized, as corporations quickly adopt cannabinoids into their vast profile of patented medicines. Leading the charge is GW Pharmaceuticals, a UK- based pharmaceutical company who manufacturers Sativex, an outrageously overpriced oral spray that relies on THC and CBD for its medical effects. Although Sativex is not currently available to patients in the U.S., it can be prescribed in Canada, the UK and other European [...]

Continue reading »